Drug Discovery App CS WP

  1. Accelerating Structure Verification Across Novartis 5/28/2026

    Automated structure verification integrated into open-access NMR workflows cuts review time dramatically while maintaining confidence in results. See how smart parameter optimization improves efficiency.

  2. How GSK Are Revolutionizing HTE 5/28/2026

    High-throughput chemistry delivers speed and efficiency, but only with the right digital backbone. See how integrated automation and analytics help chemists extract more value from every plate.

  3. The Future Of DMTA In Drug Discovery And Development 5/28/2026

    AI‑enabled DMTA cycles connect design, experimentation, and analysis through structured data and automation, reducing manual handoffs while accelerating discovery, development, and CMC decision‑making.

  4. Multi-Technique, Vendor Neutral Analytical Data Handling For Chemists 5/21/2026

    Managing analytical data across instruments doesn’t have to slow decision-making. Learn how a vendor-neutral, multi-technique approach helps chemists access, process, and report results efficiently.

  5. Simplify And Streamline Method Development With In Silico Modeling 5/19/2026

    Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

  6. Standardization Of Analytical Data: Best Practices 5/19/2026

    Standardized analytical data is key to improving data quality, reuse, and AI readiness. Explore the challenges of fragmented formats and gain practical guidance on building future-proof foundations.

  7. Integrated Drug Discovery: Hit To PCC In 16 Months 5/8/2026

    Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.

  8. Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD) 5/6/2026

    Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.

  9. Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging 5/6/2026

    High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.

  10. A Miniaturized, Semi-Automated RNA-seq Workflow 4/20/2026

    A streamlined RNA‑seq workflow enables high‑throughput gene expression profiling directly from cell lysates, reducing cost and complexity. See how this approach accelerates lead selection.